Metabolix, Inc. (YTEN) Posts Earnings Results
Metabolix, Inc. (NASDAQ:YTEN) posted its quarterly earnings results on Thursday. The specialty chemicals company reported ($0.96) EPS for the quarter, Bloomberg Earnings reports. Metabolix had a negative net margin of 81.35% and a negative return on equity of 141.35%. The firm had revenue of $0.29 million for the quarter.
Metabolix (NASDAQ:YTEN) traded down 2.06% during midday trading on Friday, hitting $2.38. 4,626 shares of the stock were exchanged. Metabolix has a 12 month low of $0.25 and a 12 month high of $9.03. The firm’s 50 day moving average price is $3.43 and its 200 day moving average price is $1.76. The company’s market cap is $6.78 million.
Yield10 Bioscience, Inc, formerly Metabolix, Inc, is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn.
Receive News & Ratings for Metabolix Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metabolix Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.